Pancreatic Cancer Awareness Month
🎗️ Pancreatic cancer remains one of the deadliest cancers, accounting for about 3% of all cancers in the U.S. but nearly 8% of all cancer deaths. In 2025, an estimated 67,440 Americans will be diagnosed, and about 51,980 are expected to die from the disease. The overall 5-year relative survival rate is just 13% — […]
The power of Multi-omics
Precision medicine is revolutionizing healthcare by moving from a one-size-fits-all approach to truly personalized care. A recent article published in Nature, states how the genomics revolution underpins the P4 healthcare model: predictive, preventive, personalized, and participatory medicine. Link to the article here. 🔬 This transformation is fueled by advances in genomics and the integration of […]
We will be at the Piper Sandler 2026 Conference
Big ideas meet bold insights in New York City this December! 🗽 I’m excited to share that I’ll be attending the Piper Sandler 37th Annual Healthcare Conference, happening December 2–5, 2025 — and I look forward to connecting with the industry’s most forward-thinking healthcare leaders. 🌟 At Clinakos, we’re harnessing the power of Integrated Patient […]
RWE prominence in FDA approval
A recent Springer June 2025 publication highlights RWE’s growing role in supporting safety and efficacy evaluations in supplemental FDA approvals—especially in oncology, which represented 43.6% of submissions with RWE. 📊🧬 RWE provides complementary insights beyond traditional clinical trials—now informing every stage of the product lifecycle, with regulatory bodies increasingly using it to guide drug development, […]
Inder Jaggi’s Highlights From Our Webinar
Earlier this week, I had the privilege of presenting a webinar, “Applying Patient-Level Data & AI in Rare Diseases & Oncology,”. We closed the session by demonstrating how AI can reduce up to 40% workloads for key functions like medical affairs, commercial, market research, and clinical. I want to thank everyone who joined, and I […]
NIH Strategic Data Plan
The National Institutes of Health (NIH) unveiled its ambitious 2025-2030 Strategic Plan for Data Science, highlighting a transformative vision to enhance biomedical research through innovative data science. Key priorities include making data Findable, Accessible, Interoperable, and Reusable (FAIR) — embracing global standards to maximize the impact and utility of biomedical data. This includes promoting standards […]
Pediatric Rare Disease Therapy Gap
More than 10,000 rare diseases affect over 30 million Americans, with nearly 70% appearing in childhood. Families often face long, challenging diagnostic journeys—navigating multiple specialists and fragmented medical records. Yet, only 5% of roughly 7,000 rare diseases have FDA-approved treatments. A recent study projects about 45 new pediatric rare disease therapies by 2033, but 95% […]
Prostate Cancer Awareness Month
John White, a biotechnology engineer, was no stranger to data or innovation. But when diagnosed with prostate cancer, he faced a reality that numbers can’t always predict. Standard treatments failed. So he turned to a clinical trial—where immunotherapy didn’t just extend his life. It gave it back. Read his journey—https://www.cancerresearch.org/stories/patients/john-white At Clinakos Inc., we see […]
Patient Registry makes History
Once seen as supplemental—patient registries are now becoming central tools in shaping regulatory decisions specifically for rare disease drug development. For many rare conditions and hard-to-study cancers, traditional clinical trials are simply not feasible—as there are just not enough patients. Leveraging high-quality real-world data from patient registries and natural history studies is becoming increasingly useful […]
Ovarian Cancer Awareness Month
Ovarian Cancer Awareness Month: Heleena’s Courageous Story September is more than a page on the calendar—it’s a bold call for awareness and action. At Clinakos, we’re spotlighting real patient stories, and this year, Heleena’s journey brings the message home. Just 27, Heleena noticed she wasn’t feeling herself—nothing alarming at first, just what seemed like minor […]
